NCT04136327View on ClinicalTrials.gov

A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
Healthy
Interventions
DRUG

GLPG1972 film-coated tablets

single oral dose of GLPG1972

DRUG

[14C]-GLPG1972 solution for infusion

a 15-minute IV infusion \[14C\]-GLPG1972

DRUG

[14C]-GLPG1972 oral solution

single oral dose of \[14C\]-GLPG1972

Trial Locations (1)

NG11 6JS

Quotient Sciences Limited, Nottingham

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY